Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 May;33(5):621–623. doi: 10.1128/aac.33.5.621

Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells.

D Raoult 1, M R Yeaman 1, O G Baca 1
PMCID: PMC172502  PMID: 2751278

Abstract

The relative lack of efficacy of the antibiotic treatment of chronic Q fever endocarditis justifies the further evaluation of the susceptibility of Coxiella burnetii to the modern quinolone antibiotics. We evaluated the efficacies of pefloxacin and ofloxacin in controlling the Nine Mile isolate of C. burnetii by using an embryonated egg assay and persistently infected L929 cells in culture. Pefloxacin was effective in controlling the intracellular parasite at a concentration of 50 micrograms per egg and 1 microgram/ml in cultures of infected cells. Ofloxacin was effective at a concentration of 25 micrograms per egg and 0.5 microgram/ml in infected-cell cultures. In light of the fact that the concentrations of antibiotics used fall within physiological ranges used in humans, ofloxacin and pefloxacin may be useful in the clinical management of chronic Q fever, for which, to date, results have been poor.

Full text

PDF
621

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baca O. G., Akporiaye E. T., Aragon A. S., Martinez I. L., Robles M. V., Warner N. L. Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines. Infect Immun. 1981 Jul;33(1):258–266. doi: 10.1128/iai.33.1.258-266.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baca O. G., Scott T. O., Akporiaye E. T., DeBlassie R., Crissman H. A. Cell cycle distribution patterns and generation times of L929 fibroblast cells persistently infected with Coxiella burnetii. Infect Immun. 1985 Feb;47(2):366–369. doi: 10.1128/iai.47.2.366-369.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GIMENEZ D. F. STAINING RICKETTSIAE IN YOLK-SAC CULTURES. Stain Technol. 1964 May;39:135–140. doi: 10.3109/10520296409061219. [DOI] [PubMed] [Google Scholar]
  4. ORMSBEE R. A., PARKER H., PICKENS E. G. The comparative effectiveness of aureomycin, terramycin, chloramphenicol erythromycin, and thiocymetin in suppressing experimental rickettsial infections in chick embryos. J Infect Dis. 1955 Mar-Apr;96(2):162–167. doi: 10.1093/infdis/96.2.162. [DOI] [PubMed] [Google Scholar]
  5. Pierce M. A., Saag M. S., Dismukes W. E., Cobbs C. G. Q fever endocarditis. Am J Med Sci. 1986 Aug;292(2):104–106. doi: 10.1097/00000441-198608000-00007. [DOI] [PubMed] [Google Scholar]
  6. Raoult D., Etienne J., Massip P., Iaocono S., Prince M. A., Beaurain P., Benichou S., Auvergnat J. C., Mathieu P., Bachet P. Q fever endocarditis in the south of France. J Infect Dis. 1987 Mar;155(3):570–573. doi: 10.1093/infdis/155.3.570. [DOI] [PubMed] [Google Scholar]
  7. Raoult D., Roussellier P., Galicher V., Perez R., Tamalet J. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob Agents Chemother. 1986 Mar;29(3):424–425. doi: 10.1128/aac.29.3.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Silberman R., Fiset P. Method for counting Rickettsiae and Chlamydiae in purified suspensions. J Bacteriol. 1968 Jan;95(1):259–261. doi: 10.1128/jb.95.1.259-261.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Tobin M. J., Cahill N., Gearty G., Maurer B., Blake S., Daly K., Hone R. Q fever endocarditis. Am J Med. 1982 Mar;72(3):396–400. doi: 10.1016/0002-9343(82)90495-8. [DOI] [PubMed] [Google Scholar]
  10. Varma M. P., Adgey A. A., Connolly J. H. Chronic Q fever endocarditis. Br Heart J. 1980 Jun;43(6):695–699. doi: 10.1136/hrt.43.6.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Williams J. C., Peacock M. G., McCaul T. F. Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components. Infect Immun. 1981 May;32(2):840–851. doi: 10.1128/iai.32.2.840-851.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Yeaman M. R., Mitscher L. A., Baca O. G. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob Agents Chemother. 1987 Jul;31(7):1079–1084. doi: 10.1128/aac.31.7.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES